Actively Recruiting
A Symptom Management Application for Children at the Early Stage of Cancer Survivorship and Their Caregivers
Led by Chinese University of Hong Kong · Updated on 2025-09-10
150
Participants Needed
2
Research Sites
47 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this randomized controlled trial is to examine the efficacy of the mHealth app in improving symptoms experienced by children in the early stage of cancer survivorship, including physical function, anxiety, depressive symptoms, fatigue, peer relationships, and pain interference, and at improving the quality of life (QoL) of the children's primary caregivers The main question it aims to answer is whether survivors who receive the symptom management mHealth app intervention will report improved symptoms, i.e., improved physical function; lower levels of anxiety, depressive symptoms, and fatigue; better peer relationships; and lower pain interference 3 months after starting the intervention. Additionally, we hypothesized that the primary caregivers (either the mother or father) would report an improved QoL 3 months after starting the intervention. Participants in the intervention group will use the mHealth app for 12 weeks with personalised nurse support via interactive communication technologies. They are required to complete questionnaires at baseline (during medical follow-up), 1, 2, and 3 months (via electronic-based systems in the mobile app) Besides, semi-structured interviews and will be conducted to examine the usability, feasibility, and acceptability of the intervention.
CONDITIONS
Official Title
A Symptom Management Application for Children at the Early Stage of Cancer Survivorship and Their Caregivers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chinese paediatric cancer survivors aged 9 to 16 years
- Able to read and communicate in Chinese
- Completed active cancer treatment within the previous 2 years
- Have a smartphone or tablet and willing to install the mHealth app
- Primary caregiver (mother or father) able to read and communicate in Chinese
- Primary caregiver has a smartphone or tablet and willing to install the mHealth app with the child
You will not qualify if you...
- Paediatric cancer survivors with cognitive impairments or psychiatric illnesses
- Paediatric cancer survivors currently participating in other symptom management studies
- Paediatric cancer survivors with evidence of secondary malignancy or cancer recurrence
- Primary caregivers with cognitive impairments or psychiatric illnesses
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Not Yet Recruiting
2
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
Research Team
A
Ankie Tan Cheung, PhD
CONTACT
W
William Ho Cheung Li, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here